down arrow

Nexalin Technology, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US65345B2016
USD
0.96
-0.01 (-0.73%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.960.99

52 Week

0.704.39
Valuation
Technical
Day's Volume

CASH

89.63 k

Shareholding (Mar 2025)

FII

0.15%

Held by 4 FIIs

DII

97.79%

Held by 2 DIIs

Promoter

0.00%

How big is Nexalin Technology, Inc.?

22-Jun-2025

As of Jun 18, Nexalin Technology, Inc. has a market capitalization of 19.51 million, with net sales of 0.14 million and a net profit of -8.55 million over the last four quarters. The company reported shareholder's funds of 3.68 million and total assets of 4.22 million as of Dec 24.

Market Cap: As of Jun 18, Nexalin Technology, Inc. has a market capitalization of 19.51 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Nexalin Technology, Inc. reported net sales of 0.14 million and a net profit of -8.55 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 3.68 million and total assets of 4.22 million.

Read More

What does Nexalin Technology, Inc. do?

22-Jun-2025

Nexalin Technology, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025, with a market cap of $19.51 million. Key financial metrics indicate it is currently loss-making with a negative return on equity and no dividend yield.

Overview:<BR>Nexalin Technology, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 19.51 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.88 <BR>Return on Equity: -367.87% <BR>Price to Book: 8.39 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Nexalin Technology, Inc. overvalued or undervalued?

25-Jun-2025

As of August 10, 2023, Nexalin Technology, Inc. is considered overvalued with troubling financial ratios, including a price-to-book value of 9.53 and a negative EV to EBITDA of -2.32, alongside a significant year-to-date stock decline of 61.96%.

As of 10 August 2023, the valuation grade for Nexalin Technology, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company appears to be overvalued, particularly given its troubling financial ratios, including a price-to-book value of 9.53 and an EV to EBITDA of -2.32. Additionally, the return on capital employed (ROCE) and return on equity (ROE) are alarmingly low at -869.22% and -367.87%, respectively.<BR><BR>In comparison to its peers, Nexalin's EV to EBITDA ratio of -2.32 is worse than that of Cardio Diagnostics Holdings, Inc. at 0.5065 and Vivos Therapeutics, Inc. at -1.0143, both of which are also struggling but show relatively better performance. The company's recent stock performance has been dismal, with a year-to-date decline of 61.96%, contrasting sharply with the S&P 500's modest gain of 2.44% during the same period. This further reinforces the notion that Nexalin Technology, Inc. is currently overvalued.

Read More

Is Nexalin Technology, Inc. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Nexalin Technology, Inc. shows a mildly bearish trend with mixed technical indicators, including a mildly bullish weekly MACD but a bearish monthly MACD, and has significantly underperformed the S&P 500 with a year-to-date return of -71.39%.

As of 3 September 2025, the technical trend for Nexalin Technology, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish. The Bollinger Bands and daily moving averages are both bearish, suggesting downward pressure. The KST is mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend as well. <BR><BR>In terms of performance, Nexalin has underperformed the S&P 500 across multiple periods, with a year-to-date return of -71.39% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bearish, reflecting mixed signals but leaning towards weakness.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 14 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.97

stock-summary
Return on Equity

-148.42%

stock-summary
Price to Book

2.43

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.63%
0%
14.63%
6 Months
-23.57%
0%
-23.57%
1 Year
-77.66%
0%
-77.66%
2 Years
129.29%
0%
129.29%
3 Years
-59.02%
0%
-59.02%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nexalin Technology, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Nexalin Technology, Inc. technically bullish or bearish?

As of 3 September 2025, the technical trend for Nexalin Technology, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish. The Bollinger Bands and daily moving averages are both bearish, suggesting downward pressure. The KST is mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend as well. In terms of performance, Nexalin has underperformed the S&P 500 across multiple periods, with a year-to-date return of -71.39% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bearish, reflecting mixed signals but leaning towards weakness....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.36%
EBIT Growth (5y)
-217.45%
EBIT to Interest (avg)
-4.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.08
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.17%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.53
EV to EBIT
-2.31
EV to EBITDA
-2.32
EV to Capital Employed
20.11
EV to Sales
20.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-869.22%
ROE (Latest)
-367.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (2.05%)

Foreign Institutions

Held by 4 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 20.00% vs 28.57% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-2.00",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "-2.00",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22,962.20%",
          "val2": "-49,036.30%",
          "chgp": "2,607.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 100.00% vs -92.31% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -65.22% vs -170.59% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.70",
          "val2": "-5.70",
          "chgp": "-35.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.60",
          "val2": "-4.60",
          "chgp": "-65.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-45,961.40%",
          "val2": "-51,434.80%",
          "chgp": "547.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-1.60
-2.00
20.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.60
-2.00
20.00%
Operating Profit Margin (Excl OI)
-22,962.20%
-49,036.30%
2,607.41%
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 20.00% vs 28.57% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.20
0.10
100.00%
Operating Profit (PBDIT) excl Other Income
-7.70
-5.70
-35.09%
Interest
0.00
0.00
Exceptional Items
0.00
0.60
-100.00%
Consolidate Net Profit
-7.60
-4.60
-65.22%
Operating Profit Margin (Excl OI)
-45,961.40%
-51,434.80%
547.34%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 100.00% vs -92.31% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -65.22% vs -170.59% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Nexalin Technology, Inc. stock-summary
stock-summary
Nexalin Technology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."